These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21371533)

  • 1. Caffeine and uric acid mediate glutathione synthesis for neuroprotection.
    Aoyama K; Matsumura N; Watabe M; Wang F; Kikuchi-Utsumi K; Nakaki T
    Neuroscience; 2011 May; 181():206-15. PubMed ID: 21371533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.
    Matsumura N; Aoyama K
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A purine derivative, paraxanthine, promotes cysteine uptake for glutathione synthesis.
    Matsumura N; Kinoshita C; Bhadhprasit W; Nakaki T; Aoyama K
    J Pharmacol Sci; 2023 Jan; 151(1):37-45. PubMed ID: 36522121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
    Allameh A; Maleklou N; Zargari M; Sanati MH
    Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of neuronal glutathione synthesis by EAAC1 and its interacting protein GTRAP3-18.
    Aoyama K; Watabe M; Nakaki T
    Amino Acids; 2012 Jan; 42(1):163-9. PubMed ID: 21373771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased neuronal glutathione and neuroprotection in GTRAP3-18-deficient mice.
    Aoyama K; Wang F; Matsumura N; Kiyonari H; Shioi G; Tanaka K; Kinoshita C; Kikuchi-Utsumi K; Watabe M; Nakaki T
    Neurobiol Dis; 2012 Mar; 45(3):973-82. PubMed ID: 22210510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
    Nobre HV; Cunha GM; de Vasconcelos LM; Magalhães HI; Oliveira Neto RN; Maia FD; de Moraes MO; Leal LK; Viana GS
    Neurochem Int; 2010 Jan; 56(1):51-8. PubMed ID: 19782116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
    Cui X; Zuo P; Zhang Q; Li X; Hu Y; Long J; Packer L; Liu J
    J Neurosci Res; 2006 Jun; 83(8):1584-90. PubMed ID: 16555301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.
    Guerreiro S; Ponceau A; Toulorge D; Martin E; Alvarez-Fischer D; Hirsch EC; Michel PP
    J Neurochem; 2009 May; 109(4):1118-28. PubMed ID: 19302482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult.
    Arredondo F; Echeverry C; Abin-Carriquiry JA; Blasina F; Antúnez K; Jones DP; Go YM; Liang YL; Dajas F
    Free Radic Biol Med; 2010 Sep; 49(5):738-47. PubMed ID: 20554019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
    Cui X; Zuo P; Zhang Q; Li X; Hu Y; Long J; Packer L; Liu J
    J Neurosci Res; 2006 Aug; 84(3):647-54. PubMed ID: 16710848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.
    Aoyama K; Suh SW; Hamby AM; Liu J; Chan WY; Chen Y; Swanson RA
    Nat Neurosci; 2006 Jan; 9(1):119-26. PubMed ID: 16311588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of neuronal glutathione synthesis.
    Aoyama K; Watabe M; Nakaki T
    J Pharmacol Sci; 2008 Nov; 108(3):227-38. PubMed ID: 19008644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection.
    Amaro S; Planas AM; Chamorro A
    Expert Rev Neurother; 2008 Feb; 8(2):259-70. PubMed ID: 18271711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism.
    Singh K; Singh S; Singhal NK; Sharma A; Parmar D; Singh MP
    Chem Biol Interact; 2010 Apr; 185(2):81-93. PubMed ID: 20230807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of respiratory stimulants on hypoxic neuronal cell injury in SH-SY5Y cells and in hippocampal slice cultures from rat pups.
    Tanaka K; Ishitsuka Y; Kurauchi Y; Yamaguchi K; Kadowaki D; Irikura M; Katsuki H; Irie T
    Pediatr Int; 2013 Jun; 55(3):320-7. PubMed ID: 23461670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of glutathione synthesis via interaction between glutamate transport-associated protein 3-18 (GTRAP3-18) and excitatory amino acid carrier-1 (EAAC1) at plasma membrane.
    Watabe M; Aoyama K; Nakaki T
    Mol Pharmacol; 2007 Nov; 72(5):1103-10. PubMed ID: 17646425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.
    Sun L; Xu S; Zhou M; Wang C; Wu Y; Chan P
    Brain Res; 2010 Jun; 1335():74-82. PubMed ID: 20380823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
    Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR
    Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.